Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

Clinical trial NCT07012993 · RECRUITING

Trial details

NCT number: NCT07012993
Sponsor: Akiva Mintz
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Mild Cognitive Impairment Dementia Healthy Volunteers

Start date: 2025-05-20
Primary completion: 2030-06-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.